生命科学资讯

Roche to invest $478 million in Korea clinical trials over 5 years - koreabiomed.com

Roche to invest $481 mn in South Korea clinical trials, biotech partnerships - The Korea Economic Daily Global Edition

Roche: Sustainable Operations, Supply Chains & AI in Health - Sustainability Magazine

Roche pill succeeds in another MS study, but approval questions linger

Roche gets third pivotal win with MS drug, but liver signal could be a problem

Roche reports another phase 3 multiple sclerosis win, but deaths add to safety questions

Roche reports pivotal MS win, but deaths add to safety questions - Fierce Biotech

AI Drug Discovery: How Roche Accelerates Health Innovation - AI Magazine

Roche halts development of satralizumab for DMD bone health - Muscular Dystrophy News

Next Generation Sequencing Market Competitive Landscape Report 2025 Featuring Top Players - Thermo Fisher Scientific, Pacific Biosciences, Illumina, Roche - Yahoo Finance Singapore

Roche halts development of Enspryng in Duchenne muscular dystrophy - Fierce Pharma

Roche to stop work on bone health treatment for Duchenne

Roche to stop work on bone health treatment for Duchenne - Endpoints News

Roche gets FDA decision date on closely watched breast cancer drug

Chutes & Ladders—Roche taps Aussie oncologist to lead early research

Roche taps Aussie oncologist to lead research—Chutes & Ladders - Fierce Biotech

Clinical Trials - Roche

A circadian rheostat drives proton electrochemical gradients to optimize cell-type-specific growth in Arabidopsis

Roche to end manufacturing of key antibiotic amid EU’s generic woes - Euractiv

Paragon's new biotech Korsana tackles Alzheimer's like Roche